Zuess - So how does that go along with cancelling CD03?
You mean maybe data which they have, right?
I remember CD03 stops and all pts may continue in the followup extension trial to enjoy PRO140 further. I like this notion of the extension trial, nice to 'em.
But .. regardless. No new detailed statistical meaningful data until we have the next monotrial going. IMHO.
A bit more cash and finishing off Combo should be catalyst enough, no? Remember, SP was here when world thought mono is impossible. Now early data showed there is reasonable hope.
Would be great if this could be pushed through and FDA exclusivity been granted long enough for revenues.
Hence my ever annoying repetitive begging to CYDY:
Please raise enough money ASAP to finish those things.
In contrast to Nader who talks about that they just cannot raise $100M at 40c-50c due to .. I don't know.
Speaking of generics and PRO140's cheap price tag, maybe CYDY should knock at TEVA's door?
News 
Market Data 
Discover 
